Almirall S.A. Logo

Almirall S.A.

Global biopharmaceutical company specializing in medical dermatology and skin health.

ALM | MC

Overview

Corporate Details

ISIN(s):
ES0157097017
LEI:
95980020140005007996
Country:
Spain
Address:
Ronda General Mitre 151, 08022 Barcelona

Description

Almirall S.A. is a global biopharmaceutical company specializing in medical dermatology. The company focuses on the research, development, manufacturing, and commercialization of proprietary medicines to address significant unmet needs in skin health. Leveraging scientific innovation, Almirall provides medical solutions designed to improve the well-being and quality of life for patients. Its operations encompass in-house research and development, strategic partnerships, and in-licensing to expand its portfolio of dermatological treatments.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-17 18:19
Almirall ha procedido al cierre y desembolso de su emisión de obligaciones simp…
Spanish 184.0 KB
2025-05-12 07:33
Información sobre el calendario del dividendo
Spanish 104.4 KB
2025-05-12 07:23
Información sobre dividendos
Spanish 188.2 KB
2025-05-12 07:15
Acuerdos adoptados por el Consejo de Administración
Spanish 105.9 KB
2025-05-12 07:04
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-05-12 06:57
Almirall remite presentación sobre los resultados del primer trimestre de 2025 …
Spanish 1.3 MB
2025-05-12 06:51
Almirall realizará una presentación vía webcast para explicar los Resultados de…
Spanish 101.3 KB
2025-05-12 00:00
Acuerdos adoptados por la Junta General de Accionistas 2025
Spanish 182.9 KB
2025-04-09 11:58
Operaciones del contrato de liquidez durante el primer trimestre de 2025
English 187.4 KB
2025-04-01 13:17
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-04-01 00:00
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025 -…
Spanish 279.9 KB
2025-03-31 17:58
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-31 00:00
Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad 2025
Spanish 141.0 KB
2025-03-06 07:28
Almirall anuncia el plan de transición del CFO
Spanish 72.6 KB
2025-02-24 06:43
La sociedad remite presentación sobre los resultados del ejercicio 2024
Spanish 1.3 MB

Automate Your Workflow. Get a real-time feed of all Almirall S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Almirall S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Almirall S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Edesa Biotech, Inc. Logo
Clinical-stage biopharma developing therapies for inflammatory and immune diseases.
United States of America
EDSA
Edgewise Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for rare muscle and cardiac disorders.
United States of America
EWTX
Egetis Therapeutics Logo
Develops and commercializes treatments for serious and rare diseases.
Sweden
EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, medical equipment, and gene amplification technology.
Japan
4549
Eisai Co., Ltd. Logo
A research-based pharmaceutical company focused on neurology and oncology treatments.
Japan
4523
Elanco Animal Health Inc Logo
Develops products and services to prevent and treat diseases in farm animals and pets.
United States of America
ELAN
Elanix Biotechnologies AG Logo
Develops products from progenitor cells for wound care and dermatological applications.
Germany
ELN
ELI LILLY & Co Logo
A research-based company that develops and sells pharmaceutical products.
United States of America
LLY
Ellen AB Logo
Biotechnology company developing products for women's intimate health.
Sweden
ELN
ELUTIA INC. Logo
Develops drug-eluting biomaterials for medical implants and tissue reconstruction.
United States of America
ELUT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.